Jpmorgan Chase & CO Assertio Holdings, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,906 shares of ASRT stock, worth $3,320. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,906
Previous 10,478
62.72%
Holding current value
$3,320
Previous $12,000
75.0%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ASRT
# of Institutions
101Shares Held
30.5MCall Options Held
957KPut Options Held
38.5K-
Nantahala Capital Management, LLC New Canaan, CT8.95MShares$7.61 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$3.73 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.99MShares$2.54 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.18 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT1.26MShares$1.07 Million0.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $41M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...